+462.0%
MRNA vs ALK
-35.4%
+497.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.6% | +1.4% | +0.8% |
| 7D | -8.2% | -3.1% | -5.1% | -7.8% |
| 30D | +125.6% | -17.1% | +142.7% | +135.5% |
| 3M | +197.1% | -3.8% | +200.8% | +196.6% |
| 6M | +148.5% | -5.3% | +153.8% | +145.0% |
| YTD | +363.3% | -20.3% | +383.5% | +364.4% |
| 1Y | +462.0% | -36.0% | +498.0% | +420.9% |
| All | +462.0% | -35.4% | +497.4% | +420.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ALK.
Daily Out/Under-Performance
Portfolio return minus ALK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling